Insider sale
CASI PHARMACEUTICALS, INC.
$1.46M
305K shares
What this filing means
PANACEA INNOVATION LTD plans to sell 305K shares of CASI PHARMACEUTICALS, INC. valued at approximately $1.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/15/2024ACC: 0000950170-24-032447
305K
Shares to sell
$1.46M
Approx. market value
371.52K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
9/8/2022
371.52KTotal acquired371.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2022 | Open Market Purchase Cash | 371.52K | — |
| Total | 371.52K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
134K
Market value
$925.9K
3/5/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
171K
Market value
$534.2K
3/15/2024
Total
Units
305K
Value
$1.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2024 | 134K | $925.9K | — | Completed |
| Planned — Approximate Date | ||||
3/15/2024 | 171K | $534.2K | NASDAQ | Planned |
| Total | 305K | $1.46M | ||